New and upcoming biologic agents for rheumatoid arthritis.
Beavers
Craig
C
University of Kentucky, UKHealthCare, Lexington, Kentucky, USA. cjbeav2@uky.edu
Adams
Aimee
A
Smith
Kelly M
KM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000627:therapeutic use*; D008297:Male; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D018836:Inflammation Mediators